Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/4153
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorOLIVEIRA, Cristina Mendes de-
dc.contributor.authorFREGNANI, Jose Humberto Tavares Guerreiro-
dc.contributor.authorCARVALHO, Jesus Paula-
dc.contributor.authorLONGATTO-FILHO, Adhemar-
dc.contributor.authorLEVI, Jose Eduardo-
dc.date.accessioned2014-01-28T22:25:22Z-
dc.date.available2014-01-28T22:25:22Z-
dc.date.issued2013-
dc.identifier.citationBMC CANCER, v.13, article ID 357, 8p, 2013-
dc.identifier.issn1471-2407-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/4153-
dc.description.abstractBackground: Invasive cervical cancer is the second most common malignant tumor affecting Brazilian women. Knowledge on Human Papillomavirus (HPV) genotypes in invasive cervical cancer cases is crucial to guide the introduction and further evaluate the impact of new preventive strategies based on HPV. We aimed to provide updated comprehensive data about the HPV types' distribution in patients with invasive cervical cancer. Methods: Fresh tumor tissue samples of histologically confirmed invasive cervical cancer were collected from 175 women attending two cancer reference hospitals from Sao Paulo State: ICESP and Hospital de Cancer de Barretos. HPV detection and genotyping were performed by the Linear Array HPV Genotyping Test (Roche Molecular Diagnostics, Pleasanton, USA). Results: 170 out of 172 valid samples (99%) were HPV DNA positive. The most frequent types were HPV16 (77.6%), HPV18 (12.3%), HPV31 (8.8%), HPV33 (7.1%) and HPV35 (5.9%). Most infections (75%) were caused by individual HPV types. Women with adenocarcinoma were not younger than those with squamous cell carcinoma, as well, as women infected with HPV33 were older than those infected by other HPV types. Some differences between results obtained in the two hospitals were observed: higher overall prevalence of HPV16, absence of single infection by HPV31 and HPV45 was verified in HC-Barretos in comparison to ICESP patients. Conclusions: To our knowledge, this is one of the largest studies made with fresh tumor tissues of invasive cervical cancer cases in Brazil. This study depicted a distinct HPV genotype distribution between two centers that may reflect the local epidemiology of HPV transmission among these populations. Due to the impact of these findings on cervical cancer preventive strategies, extension of this investigation to routine screening populations is warranted.-
dc.language.isoeng-
dc.publisherBIOMED CENTRAL LTD-
dc.relation.ispartofBMC Cancer-
dc.rightsopenAccess-
dc.subjectHuman Papillomavirus (HPV)-
dc.subjectInvasive cervical cancer (ICC)-
dc.subjectBrazil-
dc.subject.otherworldwide-
dc.subject.otherclassification-
dc.subject.otherprevalence-
dc.subject.othercarcinomas-
dc.subject.otherneoplasia-
dc.subject.otherlesions-
dc.subject.otherupdate-
dc.subject.otherwomen-
dc.subject.otherdna-
dc.titleHuman papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil-
dc.typearticle-
dc.rights.holderCopyright BIOMED CENTRAL LTD-
dc.identifier.doi10.1186/1471-2407-13-357-
dc.identifier.pmid23883423-
dc.subject.wosOncology-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalOLIVEIRA, Cristina Mendes de:Univ Sao Paulo, Inst Trop Med, Virol Lab, Sao Paulo, Brazil-
hcfmusp.author.externalFREGNANI, Jose Humberto Tavares Guerreiro:Hosp Canc Barretos, Fundacao Pio 12, Nucleo Apoio Ao Pesquisador, Sao Paulo, Brazil-
hcfmusp.description.articlenumber357-
hcfmusp.description.volume2013-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84880369131-
hcfmusp.origem.idWOS:000322330600001-
hcfmusp.publisher.cityLONDON-
hcfmusp.publisher.countryENGLAND-
hcfmusp.relation.referenceBernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002-
hcfmusp.relation.referenceBosch FX, 2002, J CLIN PATHOL, V55, P244-
hcfmusp.relation.referenceBOSCH FX, 1995, J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796-
hcfmusp.relation.referenceBouvard V, 2009, LANCET ONCOL, V10, P321-
hcfmusp.relation.referenceCampbell CMP, 2012, INT J GYNECOL OBSTET, V116, P47, DOI 10.1016/j.ijgo.2011.08.008-
hcfmusp.relation.referenceCastellsague X, 2006, J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067-
hcfmusp.relation.referenceDalstein V, 2009, J VIROL METHODS, V156, P77, DOI 10.1016/j.jviromet.2008.11.002-
hcfmusp.relation.referencede Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8-
hcfmusp.relation.referencede Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033-
hcfmusp.relation.referenceELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18-
hcfmusp.relation.referenceFerlay J, 2010, GLOBOCAN 2008 V2 0 C-
hcfmusp.relation.referenceFernandes José V, 2010, BMC Res Notes, V3, P96, DOI 10.1186/1756-0500-3-96-
hcfmusp.relation.referenceFIGO, 2009, GYNECOL ONCOL, V115, P325-
hcfmusp.relation.referenceGreer C E, 1991, PCR Methods Appl, V1, P46-
hcfmusp.relation.referenceINCA, 2011, EST 2012 INC CANC NO-
hcfmusp.relation.referenceKasamatsu E, 2012, J MED VIROL, V84, P1628, DOI 10.1002/jmv.23373-
hcfmusp.relation.referenceLevi JE, 1998, INT J CANCER, V76, P779, DOI 10.1002/(SICI)1097-0215(19980610)76:6<779::AID-IJC1>3.0.CO;2-V-
hcfmusp.relation.referenceLi N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396-
hcfmusp.relation.referenceLorenzato F, 2000, INT J GYNECOL CANCER, V10, P143, DOI 10.1046/j.1525-1438.2000.00007.x-
hcfmusp.relation.referenceMunoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641-
hcfmusp.relation.referenceNoronha V, 1999, Rev Soc Bras Med Trop, V32, P235, DOI 10.1590/S0037-86821999000300003-
hcfmusp.relation.referenceOliveira CM, 2012, GYNECOL ONCOL, V2, P18-
hcfmusp.relation.referenceRabelo-Santos SH, 2003, MEM I OSWALDO CRUZ, V98, P181, DOI 10.1590/S0074-02762003000200003-
hcfmusp.relation.referenceSchiffman M, 2003, J NATL CANC I MONOGR, V31, P14-
hcfmusp.relation.referenceSchiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002-
hcfmusp.relation.referenceSmith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527-
hcfmusp.relation.referenceVinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754-
hcfmusp.relation.referenceWalboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus27-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MOG
Departamento de Obstetrícia e Ginecologia - FM/MOG

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/14
LIM/14 - Laboratório de Investigação em Patologia Hepática

Artigos e Materiais de Revistas Científicas - LIM/52
LIM/52 - Laboratório de Virologia

Artigos e Materiais de Revistas Científicas - LIM/58
LIM/58 - Laboratório de Ginecologia Estrutural e Molecular

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_CARVALHO_Human_papillomavirus_genotypes_distribution_in_175_invasive_cervical_2013.PDFpublishedVersion (English)323.76 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.